US Stock MarketDetailed Quotes

FDMT 4D Molecular Therapeutics

Watchlist
  • 15.140
  • -3.060-16.81%
Close Jul 18 16:00 ET
782.79MMarket Cap-6415P/E (TTM)

4D Molecular Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-90.60%28K
562.29%20.72M
-101.52%-19K
3,940.80%20.2M
47.53%239K
-75.55%298K
-82.65%3.13M
1,255.43%1.25M
-63.40%500K
-98.89%162K
Operating revenue
-90.60%28K
562.29%20.72M
-101.52%-19K
3,940.80%20.2M
47.53%239K
-75.55%298K
-82.65%3.13M
1,255.43%1.25M
-63.40%500K
-98.89%162K
Cost of revenue
Gross profit
Operating expense
25.52%38.16M
18.05%133.59M
22.24%36.63M
26.61%34.18M
13.25%32.38M
10.12%30.4M
26.62%113.16M
20.56%29.97M
12.35%27M
28.91%28.59M
Selling and administrative expenses
28.80%10.29M
10.90%36.49M
25.25%10.61M
13.12%9.11M
7.65%8.79M
-2.89%7.99M
17.48%32.91M
15.54%8.47M
-1.61%8.06M
17.45%8.17M
-General and administrative expense
28.80%10.29M
10.90%36.49M
25.25%10.61M
13.12%9.11M
7.65%8.79M
-2.89%7.99M
17.48%32.91M
15.54%8.47M
-1.61%8.06M
17.45%8.17M
Research and development costs
24.35%27.87M
20.99%97.1M
21.06%26.03M
32.34%25.07M
15.48%23.58M
15.64%22.41M
30.79%80.25M
22.66%21.5M
19.57%18.94M
34.15%20.42M
Operating profit
-26.67%-38.14M
-2.58%-112.87M
-27.62%-36.65M
47.26%-13.97M
-13.05%-32.14M
-14.07%-30.11M
-54.25%-110.03M
-15.97%-28.72M
-16.92%-26.5M
-274.22%-28.43M
Net non-operating interest income expense
298.13%5.75M
374.58%12.21M
227.35%4.38M
387.55%3.88M
638.82%2.51M
1,343.00%1.44M
1,778.10%2.57M
528.85%1.34M
82.76%795K
4,757.14%340K
Non-operating interest income
298.13%5.75M
374.58%12.21M
227.35%4.38M
387.55%3.88M
638.82%2.51M
1,343.00%1.44M
1,778.10%2.57M
528.85%1.34M
82.76%795K
4,757.14%340K
Other net income (expense)
47.37%-10K
-417.14%-181K
-466.67%-11K
-1,855.56%-158K
8K
58.70%-19K
71.07%-35K
142.86%3K
169.23%9K
Other non- operating income (expenses)
47.37%-10K
-417.14%-181K
-466.67%-11K
-1,855.56%-158K
--8K
58.70%-19K
71.07%-35K
142.86%3K
169.23%9K
----
Income before tax
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-50.73%-107.49M
-9.15%-27.38M
-15.52%-25.69M
-270.09%-28.09M
Income tax
Net income
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-50.73%-107.49M
-9.15%-27.38M
-15.52%-25.69M
-270.09%-28.09M
Net income continuous Operations
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-50.73%-107.49M
-9.15%-27.38M
-15.52%-25.69M
-270.09%-28.09M
Minority interest income
Net income attributable to the parent company
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-50.73%-107.49M
-9.15%-27.38M
-15.52%-25.69M
-270.09%-28.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-50.73%-107.49M
-9.15%-27.38M
-15.52%-25.69M
-270.09%-28.09M
Basic earnings per share
25.00%-0.66
22.29%-2.58
8.33%-0.77
69.62%-0.24
11.49%-0.77
-7.32%-0.88
-29.18%-3.32
1.18%-0.84
3.66%-0.79
-210.71%-0.87
Diluted earnings per share
25.00%-0.66
22.29%-2.58
8.33%-0.77
69.62%-0.24
11.49%-0.77
-7.32%-0.88
-29.18%-3.32
1.18%-0.84
3.66%-0.79
-210.71%-0.87
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -90.60%28K562.29%20.72M-101.52%-19K3,940.80%20.2M47.53%239K-75.55%298K-82.65%3.13M1,255.43%1.25M-63.40%500K-98.89%162K
Operating revenue -90.60%28K562.29%20.72M-101.52%-19K3,940.80%20.2M47.53%239K-75.55%298K-82.65%3.13M1,255.43%1.25M-63.40%500K-98.89%162K
Cost of revenue
Gross profit
Operating expense 25.52%38.16M18.05%133.59M22.24%36.63M26.61%34.18M13.25%32.38M10.12%30.4M26.62%113.16M20.56%29.97M12.35%27M28.91%28.59M
Selling and administrative expenses 28.80%10.29M10.90%36.49M25.25%10.61M13.12%9.11M7.65%8.79M-2.89%7.99M17.48%32.91M15.54%8.47M-1.61%8.06M17.45%8.17M
-General and administrative expense 28.80%10.29M10.90%36.49M25.25%10.61M13.12%9.11M7.65%8.79M-2.89%7.99M17.48%32.91M15.54%8.47M-1.61%8.06M17.45%8.17M
Research and development costs 24.35%27.87M20.99%97.1M21.06%26.03M32.34%25.07M15.48%23.58M15.64%22.41M30.79%80.25M22.66%21.5M19.57%18.94M34.15%20.42M
Operating profit -26.67%-38.14M-2.58%-112.87M-27.62%-36.65M47.26%-13.97M-13.05%-32.14M-14.07%-30.11M-54.25%-110.03M-15.97%-28.72M-16.92%-26.5M-274.22%-28.43M
Net non-operating interest income expense 298.13%5.75M374.58%12.21M227.35%4.38M387.55%3.88M638.82%2.51M1,343.00%1.44M1,778.10%2.57M528.85%1.34M82.76%795K4,757.14%340K
Non-operating interest income 298.13%5.75M374.58%12.21M227.35%4.38M387.55%3.88M638.82%2.51M1,343.00%1.44M1,778.10%2.57M528.85%1.34M82.76%795K4,757.14%340K
Other net income (expense) 47.37%-10K-417.14%-181K-466.67%-11K-1,855.56%-158K8K58.70%-19K71.07%-35K142.86%3K169.23%9K
Other non- operating income (expenses) 47.37%-10K-417.14%-181K-466.67%-11K-1,855.56%-158K--8K58.70%-19K71.07%-35K142.86%3K169.23%9K----
Income before tax -12.97%-32.4M6.19%-100.84M-17.91%-32.28M60.08%-10.26M-5.45%-29.62M-8.90%-28.68M-50.73%-107.49M-9.15%-27.38M-15.52%-25.69M-270.09%-28.09M
Income tax
Net income -12.97%-32.4M6.19%-100.84M-17.91%-32.28M60.08%-10.26M-5.45%-29.62M-8.90%-28.68M-50.73%-107.49M-9.15%-27.38M-15.52%-25.69M-270.09%-28.09M
Net income continuous Operations -12.97%-32.4M6.19%-100.84M-17.91%-32.28M60.08%-10.26M-5.45%-29.62M-8.90%-28.68M-50.73%-107.49M-9.15%-27.38M-15.52%-25.69M-270.09%-28.09M
Minority interest income
Net income attributable to the parent company -12.97%-32.4M6.19%-100.84M-17.91%-32.28M60.08%-10.26M-5.45%-29.62M-8.90%-28.68M-50.73%-107.49M-9.15%-27.38M-15.52%-25.69M-270.09%-28.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -12.97%-32.4M6.19%-100.84M-17.91%-32.28M60.08%-10.26M-5.45%-29.62M-8.90%-28.68M-50.73%-107.49M-9.15%-27.38M-15.52%-25.69M-270.09%-28.09M
Basic earnings per share 25.00%-0.6622.29%-2.588.33%-0.7769.62%-0.2411.49%-0.77-7.32%-0.88-29.18%-3.321.18%-0.843.66%-0.79-210.71%-0.87
Diluted earnings per share 25.00%-0.6622.29%-2.588.33%-0.7769.62%-0.2411.49%-0.77-7.32%-0.88-29.18%-3.321.18%-0.843.66%-0.79-210.71%-0.87
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg